Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
New guidelines recommend newborns with Down’s syndrome to receive leukemia test

New guidelines recommend newborns with Down’s syndrome to receive leukemia test

Researchers identify racial differences in breast cancer immune microenvironment

Researchers identify racial differences in breast cancer immune microenvironment

Protein inhibitor drug found to be safe and effective in treating patients with acute myeloid leukemia

Protein inhibitor drug found to be safe and effective in treating patients with acute myeloid leukemia

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Scientists identify new potential target to combat acute myeloid leukemia

Scientists identify new potential target to combat acute myeloid leukemia

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

Researchers test new cancer research model that may reduce cost and speed up studies

Researchers test new cancer research model that may reduce cost and speed up studies

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

New case study shows CAR T therapy as viable option for AML patients

New case study shows CAR T therapy as viable option for AML patients

New findings point to potential therapeutic avenues for leukemia

New findings point to potential therapeutic avenues for leukemia

Moving beyond traditional 'magic bullet' approach for discovering new drugs

Moving beyond traditional 'magic bullet' approach for discovering new drugs

Researchers identify novel pathway in development of AML with poor prognosis

Researchers identify novel pathway in development of AML with poor prognosis

Experimental peptide drug shows promise against acute myeloid leukemia

Experimental peptide drug shows promise against acute myeloid leukemia

New class of drug holds potential to help patients with treatment-resistant cancers

New class of drug holds potential to help patients with treatment-resistant cancers

Researchers probe RNA epigenetics and chromatin structures to predict drug resistance in leukemia

Researchers probe RNA epigenetics and chromatin structures to predict drug resistance in leukemia

Researchers discover key inner control mechanism of cell's 'smart glue'

Researchers discover key inner control mechanism of cell's 'smart glue'

New NK cell-based immunotherapy effective against several types of leukemia

New NK cell-based immunotherapy effective against several types of leukemia

Researchers solve crystal structure for enzyme that plays key role in DNA methylation

Researchers solve crystal structure for enzyme that plays key role in DNA methylation

Modular gene enhancers may be suitable target in treatment of blood cancer

Modular gene enhancers may be suitable target in treatment of blood cancer

FDA grants approval for first drug to treat inherited breast cancer

FDA grants approval for first drug to treat inherited breast cancer